EXPOSURE-MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1) RESPONSE ANALYSIS OF THE MDM2 ANTAGONIST KRT-232 IN PATIENTS WITH ADVANCED SOLID TUMORS, MULTIPLE MYELOMA, OR ACUTE MYELOID LEUKEMIA
EHA Library, Martine Allard,
294438
SORAFENIB AS MAINTENANCE FOR PREVENTING RELAPSE IN FLT3-ITD ACUTE MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN RANDOMIZED, MULTICENTER, PHASE 3 TRIAL
EHA Library, Li Xuan,
294449
TAGRAXOFUSP (SL-401), A CD123-DIRECTED THERAPY, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN): GENOMIC LANDSCAPE AND LONG-TERM RESULTS OF A LANDMARK CLINICAL TRIAL
EHA Library, Naveen Pemmaraju,
294451
UPDATE FROM THE ONGOING PHASE I MULTINATIONAL STUDY OF MCLA-117, A BISPECIFIC CLEC12A X CD3 T-CELL ENGAGER, IN PATIENTS (PTS) WITH ACUTE MYELOGENOUS LEUKEMIA (AML)
EHA Library, John Mascarenhas,
294456
FIRST-IN-HUMAN STUDY OF A TRAIL RECEPTOR AGONIST FUSION PROTEIN, EFTOZANERMIN ALFA, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Mojca Jongen-Lavrencic,
294507
RESULTS FROM A PHASE 1 DOSE-FINDING STUDY OF CC-90009, A CEREBLON E3 LIGASE MODULATOR AND FIRST-IN-CLASS GSPT1 DEGRADER, IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (RR AML)
EHA Library, Amer M. Zeidan,
294516